Archaeabacteria viruses

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA

C12N2792/00Archaeabacteria viruses

C12N2792/00011Archaeabacteria viruses C12N2792/00021Viruses as such C12N2792/00022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2792/00023Virus like particles [VLP] C12N2792/00031Uses of virus other than therapeutic or vaccine C12N2792/00032Use of virus as therapeutic agent, other than vaccine C12N2792/00033Use of viral protein as therapeutic agent other than vaccine C12N2792/00034Use of virus or viral component as vaccine C12N2792/00041Use of virus, viral particle or viral elements as a vector C12N2792/00042virus or viral particle as vehicle C12N2792/00043viral genome or elements thereof as genetic vector C12N2792/00044Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2792/00045Special targeting system for viral vectors C12N2792/00051Methods of production or purification of viral material C12N2792/00052relating to complementing cells and packaging systems for producing virus or viral particles C12N2792/00061Methods of inactivation or attenuation C12N2792/00062by genetic engineering C12N2792/00063by chemical treatment C12N2792/00064by serial passage C12N2792/00071Demonstrated in vivo effect C12N2792/00088For redistribution C12N2792/10011Fuselloviridae C12N2792/10021Viruses as such C12N2792/10022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2792/10023Virus like particles [VLP] C12N2792/10031Uses of virus other than therapeutic or vaccine C12N2792/10032Use of virus as therapeutic agent, other than vaccine C12N2792/10033Use of viral protein as therapeutic agent other than vaccine C12N2792/10034Use of virus or viral component as vaccine C12N2792/10041Use of virus, viral particle or viral elements as a vector C12N2792/10042virus or viral particle as vehicle C12N2792/10043viral genome or elements thereof as genetic vector C12N2792/10044Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2792/10045Special targeting system for viral vectors C12N2792/10051Methods of production or purification of viral material C12N2792/10052relating to complementing cells and packaging systems for producing virus or viral particles C12N2792/10061Methods of inactivation or attenuation C12N2792/10062by genetic engineering C12N2792/10063by chemical treatment C12N2792/10064by serial passage C12N2792/10071Demonstrated in vivo effect C12N2792/10088For redistribution C12N2792/12011Guttaviridae C12N2792/12021Viruses as such C12N2792/12022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2792/12023Virus like particles [VLP] C12N2792/12031Uses of virus other than therapeutic or vaccine C12N2792/12032Use of virus as therapeutic agent, other than vaccine C12N2792/12033Use of viral protein as therapeutic agent other than vaccine C12N2792/12034Use of virus or viral component as vaccine C12N2792/12041Use of virus, viral particle or viral elements as a vector C12N2792/12042virus or viral particle as vehicle C12N2792/12043viral genome or elements thereof as genetic vector C12N2792/12044Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2792/12045Special targeting system for viral vectors C12N2792/12051Methods of production or purification of viral material C12N2792/12052relating to complementing cells and packaging systems for producing virus or viral particles C12N2792/12061Methods of inactivation or attenuation C12N2792/12062by genetic engineering C12N2792/12063by chemical treatment C12N2792/12064by serial passage C12N2792/12071Demonstrated in vivo effect C12N2792/12088For redistribution